CN Patent

CN102652128A — 作为atp结合盒转运蛋白调节剂的4-氧代-1h-喹啉-3-甲酰胺

Assigned to Vertex Pharmaceuticals Inc · Expires 2012-08-29 · 14y expired

What this patent protects

本发明涉及作为ATP-结合盒(“ABC”)转运蛋白或其片段(包括囊性纤维化跨膜传导调节因子(“CFTR”))调节剂的4-氧代-1H-喹啉-3-甲酰胺、其组合物和与之有关的方法。本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。

USPTO Abstract

本发明涉及作为ATP-结合盒(“ABC”)转运蛋白或其片段(包括囊性纤维化跨膜传导调节因子(“CFTR”))调节剂的4-氧代-1H-喹啉-3-甲酰胺、其组合物和与之有关的方法。本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。

Drugs covered by this patent

Kalydeco (IVACAFTOR) · Vertex Pharms Inc

Patent Metadata

Patent number: CN102652128A
Jurisdiction: CN
Classification: —
Expires: 2012-08-29
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.